The finalists for the Ion Torrent™ Breakthrough Award 2013 are:
Cebula A, Seweryn M, Rempala GA, et al. (2013) Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature 497:258–262.
Stolle E and Moritz RFA (2013) RESTseq–efficient benchtop population genomics with RESTriction fragment sequencing. PLoS ONE 8(5):e63960.
Kimoto M, Yamashige R, Matsunaga Ki, et al. (2013) Generation of high-affinity DNA aptamers using an expanded genetic alphabet. Nat Biotech 31:453–457.
Nikiforova MN, Wald AI, Roy S, et al. (2013) Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. J Clin Endocrinol Metab. Published online before print August 26, 2013.
Hall-Mendelin S, Allcock R, Kresoje N, et al. (2013) Detection of arboviruses and other micro-organisms in experimentally infected mosquitoes using massively parallel sequencing. PLoS ONE 8(2):e58026.
Ion Torrent products are For Research Use Only. Not for Use in Diagnostic Procedures.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum—scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies' Safe Harbor Statemen
|SOURCE Life Technologies Corporation|
Copyright©2012 PR Newswire.
All rights reserved